Log in

BidaskClub Downgrades Exponent (NASDAQ:EXPO) to Hold

Last updated on Thursday, July 9th, 2020 by MarketBeat

Exponent (NASDAQ:EXPO) was downgraded by stock analysts at BidaskClub from a "buy" rating to a "hold" rating in a research report issued on Thursday, BidAskClub reports.

EXPO has been the topic of a number of other research reports. Sidoti boosted their price target on Exponent from $80.00 to $94.00 and gave the stock a "buy" rating in a research note on Tuesday, June 2nd. Zacks Investment Research lowered Exponent from a "hold" rating to a "sell" rating in a research note on Friday, July 3rd. One analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company's stock. The stock has an average rating of "Hold" and a consensus price target of $86.75.

EXPO stock opened at $78.98 on Thursday. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.81 and a quick ratio of 3.81. The business has a 50-day moving average price of $75.98 and a 200 day moving average price of $72.44. The company has a market capitalization of $4.11 billion, a P/E ratio of 49.36 and a beta of 0.26. Exponent has a 1-year low of $57.97 and a 1-year high of $83.54.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, April 30th. The business services provider reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.07. Exponent had a return on equity of 25.03% and a net margin of 20.28%. The firm had revenue of $99.70 million during the quarter, compared to the consensus estimate of $101.21 million. During the same period in the previous year, the company posted $0.42 earnings per share. The firm's quarterly revenue was up 7.2% on a year-over-year basis. On average, analysts anticipate that Exponent will post 1.33 earnings per share for the current fiscal year.

In other Exponent news, VP Bradley A. James sold 4,370 shares of Exponent stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $67.56, for a total transaction of $295,237.20. Following the transaction, the vice president now directly owns 3,120 shares of the company's stock, valued at $210,787.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Harri Kytomaa sold 1,700 shares of Exponent stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $75.07, for a total transaction of $127,619.00. Following the transaction, the vice president now directly owns 10,661 shares in the company, valued at $800,321.27. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 60,070 shares of company stock valued at $4,545,523. Corporate insiders own 2.20% of the company's stock.

Several hedge funds have recently made changes to their positions in the stock. Victory Capital Management Inc. grew its holdings in Exponent by 26.8% during the 4th quarter. Victory Capital Management Inc. now owns 13,111 shares of the business services provider's stock worth $905,000 after acquiring an additional 2,774 shares in the last quarter. Bank of Montreal Can raised its holdings in shares of Exponent by 13.3% in the fourth quarter. Bank of Montreal Can now owns 12,165 shares of the business services provider's stock valued at $840,000 after buying an additional 1,428 shares during the last quarter. Great West Life Assurance Co. Can acquired a new position in Exponent in the 4th quarter valued at about $4,383,000. Citigroup Inc. increased its position in Exponent by 7.5% in the 4th quarter. Citigroup Inc. now owns 40,346 shares of the business services provider's stock valued at $2,785,000 after acquiring an additional 2,806 shares during the period. Finally, ProShare Advisors LLC increased its position in Exponent by 17.1% in the 4th quarter. ProShare Advisors LLC now owns 8,439 shares of the business services provider's stock valued at $582,000 after acquiring an additional 1,231 shares during the period. Hedge funds and other institutional investors own 88.84% of the company's stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Recommended Story: Market Timing - The Benefits and the Danger

Analyst Recommendations for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

15 Stocks that Insiders Love

An insider trade occurs when a corporate executive (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Company insiders are required by law to regularly report their stock purchases and sales to the SEC.

Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. If a number of insiders purchase more shares of their company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

For example, if Microsoft's CEO, CFO and COO all recently purchased additional shares of Microsoft stock, that would be an indication that there could be unreported news that may positively effect Microsoft's stock price in the near future.

This slideshow lists the 15 companies that have had the highest levels of insider buying within the last 180 days.

View the "15 Stocks that Insiders Love".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.